Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,247 total articles
Teresa Briggs, a director at DocuSign, Inc., executed multiple stock transactions in May and June 2026. She sold shares pursuant to a Rule 10b5-1 plan and simultaneously acquired shares resulting from the vesting of Restricted Stock Units (RSUs). Separately, she was granted additional RSUs. The company continues to announce significant technologica…
Docusign director James A. Beer executed a sale of common stock on June 2, 2026, through a pre-arranged trading plan. This transaction occurred as the company prepares for its earnings report. The article details Mr. Beer's recent vesting and granting of Restricted Stock Units (RSUs), alongside Docusign's major platform enhancements including new A…
Anna Marrs, a director at DocuSign, Inc., executed a sale of company common stock on June 2, 2026. This disposal was managed through a Rule 10b5-1 trading plan. The transaction occurred when the stock traded near $55.10, shortly before the release of earnings reports and following recent news regarding DocuSign's expansion into AI capabilities and …
Senior Vice President Claire Xu sold a portion of her NovaBridge Biosciences shares, while the company simultaneously reported encouraging data from its Phase 2a study for VIS-101 and received confirmation that its lead asset, givastomig, may qualify for accelerated FDA approval. Furthermore, NovaBridge appointed Mark Hagler as President and Chief …
Rambus director, Eric B. Stang, sold a significant block of company shares totaling $730,000 on June 1, 2026. This transaction occurred against a backdrop of positive corporate developments for Rambus Inc., including the introduction of new AI-enabled components and upgrades to its financial guidance from major investment banks.
Charles D. Boynton, Chief Financial Officer of Nextpower Inc., recently sold a substantial block of common shares. This sale occurred against a backdrop of positive analyst activity and major corporate news, specifically the planned acquisition of Prevalon Energy, which is expected to bolster Nextpower's position in solar power technology.
Robert Fauber, President and CEO of Moody's Corp, recently sold a substantial amount of company stock. This activity occurred against a backdrop of varied analyst sentiment and positive operational news for the firm.The transactions involved both direct sales and exercises of employee stock options, all executed under a pre-planned Rule 10b5-1 sche…
J. E. Davis, the CEO and President of Quest Diagnostics Inc., completed a sale of company stock valued at approximately $1.94 million on June 1, 2026. This transaction occurred while the stock traded near $193.16. Beyond this executive action, the company has announced significant financial developments, including a quarterly cash dividend and a la…
Richard G. Steele, a senior executive at Moody's Corporation, recently sold company stock valued at $71,679 through a prearranged trading plan. This transaction occurs amidst varied analyst reports and macroeconomic indicators concerning the firm. Notably, BMO Capital Markets raised its price target for Moody's, while Mizuho lowered its estimate fo…
Atmus Filtration Technologies' Chief People Officer, Renee Swan, sold 2,566 shares of common stock on June 1, 2026. The sale generated approximately $116,103. This transaction occurred against a backdrop of positive company news, including an earnings per share (EPS) figure that surpassed analyst expectations and the appointment of new senior leade…
Jacob Suen, President and CEO of Airgain Inc., sold a portion of his common stock on June 1, 2026. This transaction occurred while the stock was trading near its recent highs, raising discussion about the company's valuation relative to its strategic pivot toward mission-critical connectivity solutions.
Andrew Reardon, Chief Legal Officer of Ligand Pharmaceuticals Inc., executed a sale of common stock on June 1, 2026. This transaction occurred while the company's shares had risen significantly over the past year. Concurrently, Ligand announced its first-quarter 2026 earnings, which fell short of analyst expectations for both adjusted EPS and reven…
Stephanie Disher, the Chief Executive Officer of Atmus Filtration Technologies Inc., recently sold a significant block of company common stock. This insider selling activity occurred against a backdrop of generally positive corporate developments, including surpassing analyst expectations on first-quarter 2026 earnings per share and announcing a qu…
Executive activity at Optimum Communications, Inc. (NASDAQ:OPTU) recently included a planned sale of common stock by General Counsel Michael Olsen. This development occurs against a backdrop of mixed financial results for the quarter and a concurrent tender offer from a wholly-owned subsidiary.
Charles Masters, Senior Vice President of Atmus Filtration Technologies Inc., executed a sale of company stock totaling $130,763. This transaction occurred while the stock experienced volatility but was set against a backdrop of positive corporate news, including an earnings beat and a declared dividend. The firm also announced a key leadership app…
The Chief Financial Officer of Atmus Filtration Technologies Inc., Jack Kienzler, executed a sale of company stock valued at $232,207 on June 1, 2026. This transaction was detailed in an SEC filing and utilized proceeds to cover tax withholding related to the vesting of a launch grant award. Separately, the company announced positive financial resu…
Chief Legal Officer Michael Chen of Newegg Commerce, Inc. (NASDAQ:NEGG) recently sold shares of the company's common stock on June 1, 2026. The transaction details include the sale of 67 shares at a price of $18.18 per share, amounting to a total value of $1,218.This divestiture was executed under the framework of a Rule 10b5-1 trading plan. Follow…
Chief Scientific Officer (CSO) Jude Onyia executed a series of transactions involving Neurocrine Biosciences common stock, selling shares through a prearranged trading plan and simultaneously acquiring others by exercising non-qualified stock options. These personal trades occurred against the backdrop of significant corporate developments for Neur…
The recent filing disclosed a significant stock sale by Richard C. Cary, Controller and Chief Accounting Officer of Arthur J. Gallagher & Co., involving the disposition of company common shares. This activity is reported alongside details of Mr. Cary's remaining equity holdings, including derivative instruments and deferred compensation units. Furt…
Rezvan Mitra, Chief Accounting Officer at SailPoint, Inc., executed a stock sale totaling $149,740 on June 1, 2026. This transaction occurred while the company's common stock was trading near recent highs following a notable market surge. Despite the executive selling activity, SailPoint continues to announce strategic technological advancements an…
David Michael Barrett, CEO of Expensify Inc., executed a transaction selling 30,000 shares of Class A Common Stock. This activity occurred against the backdrop of the company reporting first-quarter 2026 earnings that missed projections, while simultaneously announcing a new integration partnership to enhance international VAT services.
Chief Regulatory Officer Ingrid Delaet recently engaged in stock transactions involving Neurocrine Biosciences common stock. The filing details a sale valued at $354,321 and an acquisition of shares resulting from the exercise of non-qualified stock options. Separately, Neurocrine reported strong Q1 2026 financial results, exceeding expectations fo…
The Isely Charity recently executed a significant sale of shares in Natural Grocers by Vitamin Cottage, Inc. (NASDAQ:NGVC). This transaction occurred alongside mixed financial news regarding the company's second-quarter fiscal 2026 results. While NGVC reported an earnings per share (EPS) that slightly beat expectations, its revenue fell short of an…
Katayoun Motiey, Chief Legal Admin Sust Officer at Extreme Networks Inc. (NASDAQ:EXTR), sold a total of 15,000 shares of the company's common stock worth $427,500 over two consecutive trading days in June 2026. These sales occurred while EXTR stock is near its 52-week high and following recent reports of strong financial performance and positive an…
Dryden L. Dyson, a director at Lindblad Expeditions Holdings, Inc., recently sold a notable quantity of the company’s common stock. This transaction occurred against a backdrop of strong financial reporting for the first quarter of 2026, where the firm reported an earnings per share (EPS) significantly above expectations and revenue that surpassed …
